These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24798282)
1. Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors. Corona A; Schneider A; Schweimer K; Rösch P; Wöhrl BM; Tramontano E Antimicrob Agents Chemother; 2014 Jul; 58(7):4086-93. PubMed ID: 24798282 [TBL] [Abstract][Full Text] [Related]
2. A 2-Hydroxyisoquinoline-1,3-Dione Active-Site RNase H Inhibitor Binds in Multiple Modes to HIV-1 Reverse Transcriptase. Kirby KA; Myshakina NA; Christen MT; Chen YL; Schmidt HA; Huber AD; Xi Z; Kim S; Rao RK; Kramer ST; Yang Q; Singh K; Parniak MA; Wang Z; Ishima R; Sarafianos SG Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760905 [TBL] [Abstract][Full Text] [Related]
3. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro. Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638 [TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones. Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178 [TBL] [Abstract][Full Text] [Related]
5. The solution structure of the prototype foamy virus RNase H domain indicates an important role of the basic loop in substrate binding. Leo B; Schweimer K; Rösch P; Hartl MJ; Wöhrl BM Retrovirology; 2012 Sep; 9():73. PubMed ID: 22962864 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular modeling of 2-Hydroxyisoquinoline-1,3-dione analogues as inhibitors of HIV reverse transcriptase associated ribonuclease H and polymerase. Tang J; Vernekar SKV; Chen YL; Miller L; Huber AD; Myshakina N; Sarafianos SG; Parniak MA; Wang Z Eur J Med Chem; 2017 Jun; 133():85-96. PubMed ID: 28384548 [TBL] [Abstract][Full Text] [Related]
7. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase. Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone. Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994 [TBL] [Abstract][Full Text] [Related]
9. Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase. Kirby KA; Marchand B; Ong YT; Ndongwe TP; Hachiya A; Michailidis E; Leslie MD; Sietsema DV; Fetterly TL; Dorst CA; Singh K; Wang Z; Parniak MA; Sarafianos SG Antimicrob Agents Chemother; 2012 Apr; 56(4):2048-61. PubMed ID: 22252812 [TBL] [Abstract][Full Text] [Related]
10. Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives. Corona A; Di Leva FS; Thierry S; Pescatori L; Cuzzucoli Crucitti G; Subra F; Delelis O; Esposito F; Rigogliuso G; Costi R; Cosconati S; Novellino E; Di Santo R; Tramontano E Antimicrob Agents Chemother; 2014 Oct; 58(10):6101-10. PubMed ID: 25092689 [TBL] [Abstract][Full Text] [Related]
11. Insights into the structure and activity of prototype foamy virus RNase H. Leo B; Hartl MJ; Schweimer K; Mayr F; Wöhrl BM Retrovirology; 2012 Feb; 9():14. PubMed ID: 22325739 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions. Corona A; Onnis V; Deplano A; Bianco G; Demurtas M; Distinto S; Cheng YC; Alcaro S; Esposito F; Tramontano E Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859311 [TBL] [Abstract][Full Text] [Related]
13. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6. Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261 [TBL] [Abstract][Full Text] [Related]
14. Transient kinetic analyses of the ribonuclease H cleavage activity of HIV-1 reverse transcriptase in complex with efavirenz and/or a β-thujaplicinol analogue. Herman BD; Sluis-Cremer N Biochem J; 2013 Oct; 455(2):179-84. PubMed ID: 23927736 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, activity, and structural analysis of novel α-hydroxytropolone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H. Chung S; Himmel DM; Jiang JK; Wojtak K; Bauman JD; Rausch JW; Wilson JA; Beutler JA; Thomas CJ; Arnold E; Le Grice SF J Med Chem; 2011 Jul; 54(13):4462-73. PubMed ID: 21568335 [TBL] [Abstract][Full Text] [Related]
16. Alizarine derivatives as new dual inhibitors of the HIV-1 reverse transcriptase-associated DNA polymerase and RNase H activities effective also on the RNase H activity of non-nucleoside resistant reverse transcriptases. Esposito F; Kharlamova T; Distinto S; Zinzula L; Cheng YC; Dutschman G; Floris G; Markt P; Corona A; Tramontano E FEBS J; 2011 May; 278(9):1444-57. PubMed ID: 21348941 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones. Didierjean J; Isel C; Querré F; Mouscadet JF; Aubertin AM; Valnot JY; Piettre SR; Marquet R Antimicrob Agents Chemother; 2005 Dec; 49(12):4884-94. PubMed ID: 16304149 [TBL] [Abstract][Full Text] [Related]
18. Structure of a dihydroxycoumarin active-site inhibitor in complex with the RNase H domain of HIV-1 reverse transcriptase and structure-activity analysis of inhibitor analogs. Himmel DM; Myshakina NS; Ilina T; Van Ry A; Ho WC; Parniak MA; Arnold E J Mol Biol; 2014 Jul; 426(14):2617-31. PubMed ID: 24840303 [TBL] [Abstract][Full Text] [Related]
19. Data mining and molecular dynamics analysis to detect HIV-1 reverse transcriptase RNase H activity inhibitor. Ghafoor NA; Kırboğa KK; Baysal Ö; Süzek BE; Silme RS Mol Divers; 2024 Aug; 28(4):1869-1888. PubMed ID: 37561229 [TBL] [Abstract][Full Text] [Related]
20. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities. Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]